Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070004/S047

Sientra Silicone Gel Breast Implants

Tiger Aesthetics Medical, LLC · Decision date Jul 24, 2025

FDA DECISIONP070004/S047

What did the FDA decide?

FDA records P070004/S047 as a supplement to PMA P070004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 24, 2025.

FDA approval order statement

Risk assessment for raw material processing change (i.e. filter change) was determined to be adequate.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General, Plastic Surgery
Decision date
Jul 24, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P070004/S047
Regulatory pathway
PMA supplement
Product code
FTR
Decision code
OK30
Decision date
Jul 24, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Product code
FTR
FDA device class
3

For the original device and its historical approval scope, see PMA P070004. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070004 · Original PMA

    SIENTRA SILICONE GEL BREAST IMPLANTS

  2. P070004/S047 received

    Application receipt date recorded by FDA.

  3. P070004/S047 · FDA decision

    30-Day Notice

  4. P070004/S045 · Related supplement

    Sientra Silicone Gel Breast Implants

  5. P070004/S048 · Related supplement

    Sientra Silicone Gel Breast Implants

  6. P070004/S049 · Related supplement

    Sientra Silicone Gel Breast Implants

Timeline entries are records held by MedtechLedger for P070004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070004

Product / regulatory recordCompanyPathwayDecision dateSource
Tiger Aesthetics Medical, LLCPMA approvalMar 9, 2012FDA
Tiger Aesthetics Medical, LLCPMA supplementNov 20, 2025FDA
Tiger Aesthetics Medical, LLCPMA supplementApr 22, 2026FDA
Tiger Aesthetics Medical, LLCPMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code FTR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Tiger Aesthetics Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9779 S. Franklin Dr., Suite 300, Franklin, WI, 53132

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records